Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Chlormadinone Acetate

  • Zoom
    Chlormadinone Acetate
  • Chlormadinone Acetate
Cat No: 29392
Biochemicals - Lipids
Cayman

Chlormadinone acetate is a synthetic progestin.{45702} It binds to progesterone, androgen, and glucocorticoid receptors in vitro (Kis = 2.5, 3.8, and 16 nM, respectively, for the human receptors). Chlormadinone acetate increases the number of endometr...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • 17-(acetyloxy)-6-chloro-pregna-4,6-diene-3,20-dione
Correlated keywords:
  • ?6 progesterone pregnadiene dehydroprogesterone acetoxyprogesterone Ay 13390-6 133906 Ay133906 Bellissima Bovisynchron CAP Cero Chlormadinon Chronosyn Clordion Cyclonorm Fertiletten Gestafortin Lormin Luteran Lutinyl Lutoral Syntex Matrol Menstridyl Natrol Normenon NSC92338 Prostal Retex RS 1280 RS1280 Skedule TM Synchrosyn P Traslan Verton
Product Overview:
Chlormadinone acetate is a synthetic progestin.{45702} It binds to progesterone, androgen, and glucocorticoid receptors in vitro (Kis = 2.5, 3.8, and 16 nM, respectively, for the human receptors). Chlormadinone acetate increases the number of endometrial glands and uterine weight in β-estradiol-primed rabbits when administered at a dose of 45 µg/kg per day for five days. Chlormadinone acetate reduces testosterone-induced increases in the seminal vesicle weight of castrated male rats when administered at doses of 4.6 and 21.5 mg/kg per day for eight days.
Size 250 mg
Shipping dry ice
CAS Number 302-22-7
Molecular Formula C23H29ClO4
SMILES O=C1CC[C@@]2(C)C(C(Cl)=C[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4(C(C)=O)OC(C)=O)=C1
Molecular Weight 404,9
Formulation A solid
Purity ≥98%
Custom Code 2937.23
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search